High Flow Nasal Cannula Therapy in the Pediatric Home Setting.
Shay EhrlichGolan-Tripto InbalMoran LavieMichal CahalTommy ShonfeldDario PraisHagit LevineMeir Mei ZahavOphir Bar-OnYulia GendlerJonatan ZalcmanEahab SarsurMicha AviramGoldbart AvivPatrick StaflerPublished in: Pediatric pulmonology (2022)
In our population, domestic HFNC appeared safe and well tolerated for a variety of indications. Its introduction was associated with improved weight gain, fewer hospitalization days and high parental satisfaction. Further work is required to characterize groups of children most likely to benefit from HFNC, as opposed to traditional modes of NIV. This article is protected by copyright. All rights reserved.